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PreviewsSplicing Misplaced
Newly synthesized transcripts are usually spliced
during transcription or immediately thereafter. So pre-
mRNA splicing has been presumed to occur exclu-
sively in the cell nucleus. In this issue of Cell, Denis
et al. (2005) now report the presence of functional
spliceosomes and signal-dependent pre-mRNA splic-
ing in the cytoplasm of platelets.
Cellular processes are compartmentalized to increase
efficiency and for regulatory purposes. In the case of
gene expression, the dogma has been that transcrip-
tion and pre-mRNA splicing take place in the nucleus,
whereas translation occurs in the cytoplasm. However,
dogmas exist to be proven wrong. We now know that
some transcription also takes place in mitochondria
(Gaspari et al., 2004), and it appears that translation
can occur in the nucleus (Iborra et al., 2004). In their
new study, Denis et al. (2005) add pre-mRNA splicing
to the list of misplaced nuclear processes by providing
evidence for pre-mRNA splicing in the platelet cyto-
plasm.
Platelets are highly specialized cells that circulate in
the blood and act as first responders to wounds, pro-
moting blood clotting and fighting infection. These cells
are generated in the bone marrow by a process of dif-
ferentiation in which megakaryocytes arrest their prolif-
eration and undergo extensive endoreplication result-
ing in polyploid cells that are transcriptionally highly
active. The megakaryocytes then dramatically expand
their cytoplasm, and platelets bud off from specialized
membrane regions. The forming platelets contain only
cytoplasmic components and have no nucleus (Italiano
and Hartwig, 2002; see Figure 1).
Given that anucleate platelets do not contain a ge-
nome and therefore do not carry out transcription, there
seems to be no need for these cells to have splicing
components. Contrary to this expectation, when Denis
et al. (2005) analyzed platelets and megakaryocytes,
they readily detected many essential pre-mRNA splic-
ing components, including basal splicing factors, ser-
ine-arginine-rich (SR) protein splicing factors, and small
nuclear splicing RNAs in their cytoplasm. These cyto-
plasmic components are splicing competent because
cellular extracts from platelets support splicing in vitro.
Even more remarkably, in addition to splicing factors,
resting platelets were found to also contain unspliced
pre-mRNAs in their cytoplasm (Denis et al., 2005).
But is the location of splicing factors and pre-mRNAs
in platelet cytoplasm of functional relevance? The an-
swer appears to be yes. Denis et al. (2005) provide
strong data to suggest that splicing in the cytoplasm is
a key regulatory event during platelet activation. One of
the pre-mRNAs that they discovered in platelet cyto-
plasm is that encoding the cytokine interleukin-1β (IL-
1β). The presence of this specific transcript is function-
ally relevant because synthesis of the IL-1β protein isrepressed in unstimulated platelets but dramatically in-
creases when platelets are activated. It had been as-
sumed that this regulation involved the activation of
mRNA translation. However, Denis et al. (2005) now
show that the IL-1β RNA present in the cytoplasm is
a partially spliced pre-mRNA. Upon platelet activation,
splicing is completed in a constitutive splicing reaction
in the activated platelet cytoplasm. This gives rise to
an mRNA that can be translated. Thus, pre-mRNA
splicing in platelet cytoplasm acts as a key regulatory
event in the production of IL-1β during platelet acti-
vation.
The scenario that emerges from these findings is one
in which during megakaryocyte differentiation, pre-
mRNA splicing factors as well as pre-mRNAs destined
for platelets are exported into the megakaryocyte cyto-
plasm and are incorporated into budding platelets (see
Figure 1). The splicing factors then may act constitu-
tively on pre-mRNAs or, as in the case of IL-1β, splicing
may be triggered upon activation of platelets, serving
as a regulatory switch to produce translatable mRNAs.
These results establish two fascinating new para-
digms. First, they demonstrate that pre-mRNA splicing
is not an exclusively nuclear process. Second, they in-
troduce pre-mRNA splicing as a new regulatory mecha-
nism in the cytoplasm. A precedent for cytoplasmic
splicing exists in the unfolded response pathway in
yeast, which serves to detect unfolded proteins in the
endoplasmic reticulum. However, in that case, the mech-
anism involves a highly unconventional splicing system
consisting of an endonuclease and a tRNA ligase acting
on mRNA rather than the new mechanism described
in platelets, which relies on the constitutive pre-mRNA
splicing machinery (Ruegsegger et al., 2001).
The observations by Denis et al. (2005) raise several
fundamental questions regarding the organization and
regulatory role of pre-mRNA splicing, and they point to
the existence of several unanticipated cellular mecha-
nisms. For one, it is not clear how the splicing ma-
chinery normally found in the nucleus ends up in the
cytoplasm of megakaryocytes. One possibility is that
nuclear components are actively and selectively ex-
ported into the megakaryocyte cytoplasm via a specific
export mechanism. Alternatively, the redistribution of
splicing factors might rely on the intrinsic property of
many splicing components to cycle between the nu-
cleus and the cytoplasm as part of their normal life cy-
cle. Many SR protein splicing factors normally undergo
nucleocytoplasmic shuttling, and snRNPs are exported
from the nucleus during their initial assembly (Cáceres
et al., 1998; Yong et al., 2004). Retention of these fac-
tors in the megakaryocyte cytoplasm during shuttling
would lead to their accumulation outside the nucleus.
Regardless of whether accumulation of the splicing
machinery in the cytoplasm is caused by increased ex-
port or reduced import, this redistribution likely involves
new regulatory mechanisms.
An even more puzzling question is how unspliced
pre-mRNAs manage to reach the cytoplasm. Incom-
pletely processed pre-mRNAs are usually retained
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318Figure 1. Regulatory Splicing of Pre-mRNA
in the Platelet Cytoplasm
Platelets are formed by budding of cyto-
plasm from megakaryocytes in the bone
marrow. Although the splicing machinery is
localized in the nucleus of megakaryocyte
precursor cells, splicing factors begin to ac-
cumulate in the cytoplasm of mature mega-
karyocytes. The splicing components together
with specific partially spliced pre-mRNAs are
included in the forming anucleate platelets.
Upon stimulation of platelets, the splicing
machinery is activated and completes the
splicing reaction, giving rise to a translatable
mRNA. In this way, cytoplasmic splicing acts
as a regulatory mechanism during platelet
activation.Swithin the cell nucleus and rapidly degraded by the ex-
osome as part of the cell’s RNA quality-control system
C(Jensen et al., 2003). It appears that in megakaryocytes,
1
recognition mechanisms must be in place to identify
D
the RNAs destined for platelets and to allow them to d
evade the RNA degradation machinery, possibly by as- e
yet-unidentified dedicated RNA export pathways. In the G
case of IL-1β pre-mRNA, its export might be aided by B
the partially processed nature of the transcript. Impor- I
tantly, this type of regulation is not limited to IL-1β, as 5
the authors have already found several additional pre- I
mRNAs in the platelet cytoplasm. e
It is also not clear what signaling events trigger the J
cytoplasmic splicing reaction upon platelet activation 1
and how they interface with the splicing machinery. The R
1best candidates might be some of the signaling path-
Sways previously implicated in alternative splice-site se-
7lection in other cell types (Shin and Manley, 2004). For
Yexample, the ERK signaling pathway, which regulates
2alternative splice-site selection, also has a role in plate-
let activation and might be a good candidate.
D
The most provocative question, however, is whether
pre-mRNA splicing in the cytoplasm is limited to plate-
lets or whether it might also act on at least some tran-
scripts in cell types that contain a nucleus. Although
the levels of splicing factors are generally low in the
cytoplasm of most cell types, one should keep in mind
that all proteinaceous splicing factors are synthesized
in the cytoplasm and that snRNPs are assembled there.
If some pre-mRNAs are exported from the nucleus,
these splicing components could act in the same was
as they do in platelets and support cytoplasmic, regula-
tory splicing. Although there are no other known exam-
ples of splicing in the cytoplasm, not to mention the
regulatory function of this process, it is noteworthy that
outgrowth of neuronal axons shares many hallmarks
characteristic of proplatelet morphogenesis and in-
volves spatially localized posttranscriptional RNA regu-
lation. Admittedly, this is a highly speculative scenario,
but in the light of the new work by Denis et al. (2005),
we have no choice but to realize that when it comes to
splicing, the unexpected must always be expected.
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